Marvin Edeas - A Globally Acknowledged Scientist
Lots of businesses request the expertise Marvin Edeas (nih.gov/pubmed/26500226) possesses. He is co-editor of the Mitochondria Society's company magazine and also chairs its 12-monthly congress, as a former Chair and one of the founders. Marvin Edeas chairs various committees of a scientific nature, including that of the Congress on Targeting Mitochondria, Microbiota, Non-invasive Markers in Various Chronic Pathologies and Glycation & Maillard Reaction.
Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress
Real applications have been found for the breakthroughs made by Marvin Edeas. In Europe and the US, he has filed a couple of patents. A start-up was established to promote the new peptide thanks to these patents. Using an oyster enzyme hydrolyzate within a composition that gets rid of free radicals and modulates oxidative stress is what Marvin Edeas' patents had to do with.
Marvin Edeas has been active as a visiting professor at the Cochin Institute, Paris Descartes University, ever since the year 2016. Marvin Edeas holds studies in nephrology patients and examines the impact of microbiota metabolites on mitochondrial activity of these patients. The research he carries out concentrates on the impact of Inflammation and Oxidative Stress in chronic diseases.
Chair of the International Society (ISANH) and the French Society of Antioxidants (SFA) and Founder of the World Mitochondria Society (WMS)
Marvin Edeas chairs the French Society of Antioxidants. He also chairs the ISANH (International Society of Antioxidants in Nutrition & Health) which was created in 1998 by himself. The SFA is committed to encouraging the use of antioxidants in health and nutrition, such as their use in therapeutic and preventative medicine. Marvin Edeas, ISANH and the SFA strive to transfer basic research to real applications whether pharmaceutical or clinical.